Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Learn how to leverage travel credit card points for accommodations. Enjoy amazing stays without breaking the bank.
18,425 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A new, sizable stake in Cal-Maine Foods hints at investor conviction despite a halved income last quarter. This piece...
Premium concert seats can test budgets, but smart planning makes live music affordable. This guide breaks down pricin...
XRP prices rose about 3% as data shows a 30-day average of 2.54 billion moved binance to Binance, signaling renewed w...
Investor-focused guide to perimeter solutions earnings. Learn how revenue, margins, and cash flow shape PRM stock pro...
Inside the world of insider transactions, a CFO selling shares can signal many things. This luxury good reseller's ca...
Choosing between climate-aligned global ETFs and broad international funds can shape your portfolio for years. This g...
Wall Street may be underestimating Micron's resilience. This-depth look explains why MU could surprise on the upside ...
Gold’s flagship ETF saw a record-size outflow as crypto-linked funds posted weekly gains. The week ended with mixed s...
A legendary investor makes a bold AI move. He recently closed a position in a company famous for aggressive AI spend ...
This year’s top-performing Vanguard ETF grabbed headlines with eye-catching gains. Before you dive in, learn three re...
I’ve shifted my stance on MSFT stock as the AI era deepens, driven by Azure momentum, productivity platforms, and str...